Correlation Between Viking Therapeutics and MiMedx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and MiMedx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and MiMedx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and MiMedx Group, you can compare the effects of market volatilities on Viking Therapeutics and MiMedx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of MiMedx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and MiMedx.

Diversification Opportunities for Viking Therapeutics and MiMedx

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Viking and MiMedx is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and MiMedx Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MiMedx Group and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with MiMedx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MiMedx Group has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and MiMedx go up and down completely randomly.

Pair Corralation between Viking Therapeutics and MiMedx

Given the investment horizon of 90 days Viking Therapeutics is expected to under-perform the MiMedx. In addition to that, Viking Therapeutics is 2.0 times more volatile than MiMedx Group. It trades about -0.21 of its total potential returns per unit of risk. MiMedx Group is currently generating about -0.19 per unit of volatility. If you would invest  962.00  in MiMedx Group on November 1, 2024 and sell it today you would lose (71.00) from holding MiMedx Group or give up 7.38% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Viking Therapeutics  vs.  MiMedx Group

 Performance 
       Timeline  
Viking Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viking Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
MiMedx Group 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MiMedx Group are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, MiMedx reported solid returns over the last few months and may actually be approaching a breakup point.

Viking Therapeutics and MiMedx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viking Therapeutics and MiMedx

The main advantage of trading using opposite Viking Therapeutics and MiMedx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, MiMedx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MiMedx will offset losses from the drop in MiMedx's long position.
The idea behind Viking Therapeutics and MiMedx Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.